These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 31887874)
1. Blood component ridable and CD44 receptor targetable nanoparticles based on a maleimide-functionalized chondroitin sulfate derivative. Lee JY; Lee HS; Kang NW; Lee SY; Kim DH; Kim S; Yoon IS; Cho HJ; Kim DD Carbohydr Polym; 2020 Feb; 230():115568. PubMed ID: 31887874 [TBL] [Abstract][Full Text] [Related]
2. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery. Lee JY; Chung SJ; Cho HJ; Kim DD Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228 [TBL] [Abstract][Full Text] [Related]
3. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs. Lee JY; Park JH; Lee JJ; Lee SY; Chung SJ; Cho HJ; Kim DD Carbohydr Polym; 2016 Oct; 151():68-77. PubMed ID: 27474544 [TBL] [Abstract][Full Text] [Related]
4. Self-assembled nanoparticles based on chondroitin sulfate-deoxycholic acid conjugates for docetaxel delivery: Effect of degree of substitution of deoxycholic acid. Liu M; Du H; Zhai G Colloids Surf B Biointerfaces; 2016 Oct; 146():235-44. PubMed ID: 27343846 [TBL] [Abstract][Full Text] [Related]
5. Polysaccharide-modified nanoparticles with intelligent CD44 receptor targeting ability for gene delivery. Lin WJ; Lee WC Int J Nanomedicine; 2018; 13():3989-4002. PubMed ID: 30022822 [TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel. Lee HS; Kang NW; Kim H; Kim DH; Chae JW; Lee W; Song GY; Cho CW; Kim DD; Lee JY Carbohydr Polym; 2021 Feb; 253():117187. PubMed ID: 33278965 [TBL] [Abstract][Full Text] [Related]
8. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Chen J; Li S; Shen Q; He H; Zhang Y Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153 [TBL] [Abstract][Full Text] [Related]
10. A CD44-Targeting Programmable Drug Delivery System for Enhancing and Sensitizing Chemotherapy to Drug-Resistant Cancer. Zhang M; Ma Y; Wang Z; Han Z; Gao W; Zhou Q; Gu Y ACS Appl Mater Interfaces; 2019 Feb; 11(6):5851-5861. PubMed ID: 30648841 [TBL] [Abstract][Full Text] [Related]
11. CD44 targeted-chondroitin sulfate nanoparticles: Fine-tuning hydrophobic groups to enhance in vitro pH-responsiveness and in vivo efficacy for advanced breast cancer treatment. Azimijou N; Karimi-Soflou R; Karkhaneh A Biomater Adv; 2024 Apr; 158():213776. PubMed ID: 38244368 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone. Sargazi A; Kamali N; Shiri F; Heidari Majd M Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952 [TBL] [Abstract][Full Text] [Related]
13. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery. Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles. Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657 [TBL] [Abstract][Full Text] [Related]
15. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity. Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812 [TBL] [Abstract][Full Text] [Related]
16. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer. Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758 [TBL] [Abstract][Full Text] [Related]
17. A novel double-targeted nondrug delivery system for targeting cancer stem cells. Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463 [TBL] [Abstract][Full Text] [Related]
18. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181 [TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization. Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107 [TBL] [Abstract][Full Text] [Related]
20. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery. Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]